Stockscreener 앱 받기
4.02
0.50%
-0.02
시장 영업 전:
3.95
-0.07
-1.74%
전일 마감가:
$4.04
열려 있는:
$4.06
하루 거래량:
380.72K
Relative Volume:
0.24
시가총액:
$261.39M
수익:
-
순이익/손실:
$-60.36M
주가수익비율:
-0.9149
EPS:
-4.394
순현금흐름:
$-15.05M
1주 성능:
+7.49%
1개월 성능:
-13.17%
6개월 성능:
+229.51%
1년 성능:
+82.73%
1일 변동 폭
$3.90
$4.085
1주일 범위
$3.58
$4.085
52주 변동 폭
$0.97
$4.68
Zura Bio Ltd Stock (ZURA) Company Profile
명칭
Zura Bio Ltd
전화
858-247-0520
주소
4225 EXECUTIVE SQUARE, LA JOLLA
ZURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZURA
Zura Bio Ltd
|
4.02 | 262.69M | 0 | -60.36M | -15.05M | -4.394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Zura Bio Ltd Stock (ZURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-04 | 개시 | Leerink Partners | Outperform |
| 2024-09-05 | 개시 | H.C. Wainwright | Neutral |
| 2024-05-03 | 개시 | Piper Sandler | Overweight |
| 2023-10-10 | 개시 | Ladenburg Thalmann | Buy |
| 2023-08-25 | 개시 | Oppenheimer | Outperform |
| 2023-06-22 | 개시 | Guggenheim | Buy |
| 2023-06-14 | 개시 | Chardan Capital Markets | Buy |
| 2023-05-24 | 개시 | Raymond James | Strong Buy |
모두보기
Zura Bio Ltd 주식(ZURA)의 최신 뉴스
Is Zura Bio Limited (94E) stock good for long term investingJuly 2025 Snapshot & Smart Allocation Stock Tips - Newser
How Zura Bio Limited (94E) stock expands through international marketsJuly 2025 Summary & Expert Approved Trade Ideas - Newser
How cyclical is Zura Bio Limited (94E) stock compared to rivalsJuly 2025 Breakouts & AI Enhanced Trade Execution Alerts - Newser
Bullish Outlook on Zura Bio Limited (ZURA) Amid Tibulizumab Phase 2 Clinical Trial Progress - Yahoo! Finance Canada
Leerink Partnrs Estimates Zura Bio FY2025 Earnings - Defense World
Zura Bio (NASDAQ:ZURA) Upgraded at Leerink Partnrs - Defense World
Zura Bio expresses gratitude towards team in Thanksgiving message - Traders Union
How Zura Bio Limited (94E) stock compares with tech leadersLong Setup & Fast Momentum Entry Tips - newser.com
Zura Bio (ZURA) Stock Analysis Report | Financials & Insights - Benzinga
Predicting Zura Bio Limited trend using moving averagesMarket Trend Report & Safe Capital Growth Tips - newser.com
How to escape a deep drawdown in Zura Bio LimitedQuarterly Portfolio Report & Smart Investment Allocation Insights - newser.com
Why Zura Bio Limited (94E) stock is a strong buy callQuarterly Market Review & Expert Approved Momentum Trade Ideas - newser.com
Why Zura Bio Limited (94E) stock is upgraded to buy2025 Sector Review & Community Consensus Trade Alerts - newser.com
Building trade automation scripts for Zura Bio LimitedWeekly Investment Report & Long-Term Safe Return Strategies - newser.com
Can Zura Bio Limited stock hit record highs againGlobal Markets & High Win Rate Trade Alerts - newser.com
How supply chain issues affect Zura Bio Limited stockTreasury Yields & Daily Chart Pattern Signal Reports - newser.com
Wall Street Zen Downgrades Zura Bio (NASDAQ:ZURA) to Sell - Defense World
Risk adjusted return profile for Zura Bio Limited analyzed2025 Price Action Summary & Safe Entry Trade Reports - newser.com
Zura Bio Limited (NASDAQ:ZURA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Automated trading signals detected on Zura Bio LimitedMarket Activity Report & Daily Profit Focused Stock Screening - newser.com
Clear Street initiates Zura Bio stock with Buy rating on tibulizumab potential By Investing.com - Investing.com South Africa
ZURA: Clear Street Initiates Coverage with "Buy" Rating | ZURA S - GuruFocus
Zura Bio Q3 net loss narrows despite higher R&D costs - MarketScreener
Zura Bio Ltd SEC 10-Q Report - TradingView
Zura Bio Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Zura Bio Ltd Quarterly Earnings Report | ZURA SEC FilingForm 10-Q - Stock Titan
[8-K] Zura Bio Ltd Reports Material Event | ZURA SEC FilingForm 8-K - Stock Titan
Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates - Yahoo Finance
Clear Street initiates Zura Bio stock with Buy rating on tibulizumab potential - Investing.com Canada
How does Zura Bio Ltd (ZURA) change from a tortoise to a hare? - Setenews
Zura Bio Limited recovery potential after sell offGold Moves & Real-Time Chart Breakout Alerts - newser.com
Zura Bio (NASDAQ:ZURA) Raised to “Hold” at Wall Street Zen - Defense World
Will Zura Bio Limited (94E) stock beat growth indexesTrade Risk Summary & Technical Pattern Alert System - newser.com
Is Zura Bio Limited stock attractive for passive investorsJuly 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com
Zura Bio Ltd (ZURA) looking to reclaim success with recent performance - setenews.com
Zura Bio Ltd (ZURA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):